Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Prof. Philip Hawkins, FMedSci
Healthcare Professional / Researcher Clinical Director
Division of Medicine
University College London
Gower Street
London, United Kingdom
Cardiorenal AL amyloidosis: risk stratification and outcomes based upon cardiac and renal biomarkers
High prevalence of intracardiac thrombi in cardiac amyloidosis
Natural history, quality of life, and outcome in cardiac transthyretin amyloidosis
Related Content
-
Resurrecting Tc 99m PYP: As Cardiac Amyloidosis Therapies Emerge, an Old Test Gains a New PurposeOnce used to diagnose myocardial infarct...
-
Satish Pramod Shanbhag, MBBS, MPHSatish Pramod Shanbhag is board certifie...
-
Faiz Anwer, MDFaiz Anwer is a Hematologist/Oncologist ...
-
Combination Therapy Holds Promise for Newly Diagnosed Systemic AL Amyloidosis PatientsUpdated research regarding the ANDROMEDA...
-
Multimodality Imaging of Cardiac Sarcoidosis and AmyloidosisThis live webinar will examine multimoda...
-
Improving Strategies for the Diagnosis of Cardiac AmyloidosisAmyloidosis refers to a group of rare bu...
-
Evolutive Echocardiographic Changes in Cardiac Amyloidosis: Look at the Whole PictureDoppler echocardiogram provides not only...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.